Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03699748 · ClinicalTrials.gov registry record · NA

Lay Health Worker Engage, Educate, and Encourage Patients to Share

A NA study of Cancer and End of Life, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT03699748 is a NA study of Cancer and End of Life that has completed, run by Stanford University. The registered enrollment target is 160 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03699748, a NA study of Cancer and End of Life, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The purpose of the LEAPS program is to understand how a trained lay health worker who engages with newly diagnosed patients after a diagnosis of an advanced stage of cancer can help to engage patients in advance care planning, improve patient satisfaction with their decision-making, activation, quality of life, and healthcare resource utilization.

Conditions Studied

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Lay Health Worker Intervention

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2018-11-01
Est. Completion 2022-12-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03699748

The ClinicalTrials.gov registry entry for NCT03699748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT03699748 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03699748 about?

NCT03699748 is a clinical study titled "Lay Health Worker Engage, Educate, and Encourage Patients to Share". The purpose of the LEAPS program is to understand how a trained lay health worker who engages with newly diagnosed patients after a diagnosis of an advanced stage of cancer can help to engage patients in advance care planning, improve patient satisfaction with their decision-making, activation, qual...

What is the current status of trial NCT03699748?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2018-11-01. Estimated completion is 2022-12-30.

What conditions does trial NCT03699748 study?

This clinical trial studies the following conditions: Cancer, End of Life.

What interventions are being tested in trial NCT03699748?

The interventions under investigation include: Usual Care (OTHER), Lay Health Worker Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03699748?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03699748 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.